Drug Shortage Report for NUCYNTA EXTENDED-RELEASE

Last updated on 2024-03-26 History
Report ID 208783
Drug Identification Number 02415593
Brand name NUCYNTA EXTENDED-RELEASE
Common or Proper name TAPENTADOL
Company Name ENDO VENTURES LTD.
Market Status MARKETED
Active Ingredient(s) TAPENTADOL
Strength(s) 150MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 60 tabs
ATC code N02AX
ATC description OPIOIDS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2023-10-30
Actual start date
Estimated end date 2024-03-22
Actual end date 2024-03-25
Shortage status Resolved
Updated date 2024-03-26
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD
BALLSBRIDGE, DUBLIN
IRELAND D04 H9P8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2024-03-26 English Compare
v15 2024-03-25 French Compare
v14 2024-03-25 English Compare
v13 2024-03-15 French Compare
v12 2024-03-15 English Compare
v11 2024-03-04 French Compare
v10 2024-03-04 English Compare
v9 2024-02-23 French Compare
v8 2024-02-23 English Compare
v7 2024-02-07 French Compare
v6 2024-02-07 English Compare
v5 2024-01-03 French Compare
v4 2024-01-03 English Compare
v3 2023-10-31 French Compare
v2 2023-10-31 French Compare
v1 2023-10-31 English Compare

Showing 1 to 16 of 16